Co-Diagnostics Inc (CODX)
1.105
-0.14
(-11.60%)
USD |
NASDAQ |
May 10, 16:00
1.105
0.00 (0.00%)
After-Hours: 18:52
Co-Diagnostics Revenue (Quarterly): 3.555M for Dec. 31, 2023
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 3.555M |
| September 30, 2023 | 2.457M |
| June 30, 2023 | 0.1978M |
| March 31, 2023 | 0.602M |
| December 31, 2022 | 1.402M |
| September 30, 2022 | 5.094M |
| June 30, 2022 | 5.023M |
| March 31, 2022 | 22.70M |
| December 31, 2021 | 20.40M |
| September 30, 2021 | 30.10M |
| June 30, 2021 | 27.36M |
| March 31, 2021 | 20.02M |
| December 31, 2020 | 27.15M |
| September 30, 2020 | 21.82M |
| June 30, 2020 | 24.04M |
| March 31, 2020 | 1.548M |
| Date | Value |
|---|---|
| December 31, 2019 | 0.1086M |
| September 30, 2019 | 0.0414M |
| June 30, 2019 | 0.0616M |
| March 31, 2019 | 0.0034M |
| December 31, 2018 | 0.0108M |
| September 30, 2018 | 0.0097M |
| June 30, 2018 | 0.0097M |
| March 31, 2018 | 0.0097M |
| December 31, 2017 | 0.0026M |
| September 30, 2017 | 0.0026M |
| June 30, 2017 | 0.0025M |
| March 31, 2017 | |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | 0.01M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
0.0414M
Minimum
Sep 2019
30.10M
Maximum
Sep 2021
11.25M
Average
5.023M
Median
Jun 2022
Revenue (Quarterly) Benchmarks
| PAVmed Inc | 1.049M |
| Perspective Therapeutics Inc | -5.239M |
| Electromed Inc | 13.69M |
| Xtant Medical Holdings Inc | 28.11M |
| Asensus Surgical Inc | 5.431M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -14.68M |
| Total Expenses (Quarterly) | 15.38M |
| EPS Diluted (Quarterly) | -0.50 |
| Enterprise Value | -19.47M |
| Gross Profit Margin (Quarterly) | 16.52% |
| Profit Margin (Quarterly) | -412.8% |
| Earnings Yield | -109.5% |
| Normalized Earnings Yield | -117.23 |